Health and Medical Psychology Health and Medical Humanities

Prevalence and Determinants of Relapse Among Individuals with Substance Use Disorders in Iran: A Multi-Center Study

Substance use disorders addiction prevalence relapse Iran

Authors

  • Mehran Dakhil Alian Psychiatry Resident, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Fereshteh Shakibaei
    shakibaei@med.mui.ac.ir
    Associate Professor, Child and Adolescent Psychiatrist, Behavioral Sciences Research Center, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Vol. 12 No. 9 (2025): December
Quantitative Study(ies)

Downloads

Objective: Robust, context-specific data on relapse magnitude and its determinants are essential for designing effective prevention and recovery strategies.

Methods and Materials: In a multi-center cross-sectional study, 412 adults with DSM-5 SUD were recruited from eight outpatient addiction treatment centers in three Iranian provinces. Eligible participants had completed at least one structured treatment episode and achieved a minimum of one month of abstinence. Data were collected using a structured questionnaire assessing socio-demographic and clinical characteristics, relapse history, self-reported reasons for relapse, perceived social support, abstinence self-efficacy, family conflict, craving, psychological distress, and environmental factors (drug-using network, drug availability). Relapse was defined as a return to regular problematic use after at least one month of abstinence. Bivariate tests and multivariable logistic regression were used to identify independent predictors of relapse.

Findings:  Overall, 61.9% of participants (n = 255) reported relapse after their most recent treatment episode; the median time to relapse was four months. In multivariable analysis, younger age, unemployment, primary opioid use, longer duration of use, more previous treatment episodes, and psychiatric comorbidity predicted higher relapse odds. Lower social support and abstinence self-efficacy, higher family conflict, greater craving, having at least one drug-using close contact, and perceiving drugs as easily available were also independently associated with relapse.

Conclusion:  Relapse is highly prevalent among treatment-seeking individuals with SUD in Iran and is shaped by interacting individual, interpersonal, and environmental factors. Comprehensive relapse prevention requires integrated clinical, family-based, and structural interventions tailored to these determinants.